Tom Frohlich, Chief Operating Officer at CHINOOK THERAPEUTICS, INC. (KDNY), sold 12,460 shares at $15.48 ($193K) on 2021-11-10, disclosed to the SEC on 2021-11-12.
Open-market sale of $193k KDNY by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.48 | 6,230 | $96K | 50.0% |
| 2 | $15.48 | 6,230 | $96K | 50.0% |
| Total | $15.48 avg | 12,460 | $193K | 100% |
| Filing → |
| KDNY | SELL | 2023-02-02 | $225K | — | Filing → |
| KDNY | SELL | 2022-12-15 | $250K | — | Filing → |
| KDNY | SELL | 2022-11-09 | $222K | — | Filing → |